High-flow nasal oxygen to prevent low oxygen during sedated endoscopy in people with high-risk sleep apnea
Official title: High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients: A Multicenter Randomized Trial
Run by Zhejiang University · NCT07307560 · Data updated 2026-11-12
This will test whether using high‑flow nasal oxygen instead of a regular nasal cannula prevents low oxygen levels during propofol‑sedated gastroscopy or colonoscopy in adults with high‑risk obstructive sleep apnea (STOP‑Bang ≥5).
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Zhejiang University Academic / other |
| Locations | 3 sites (Hangzhou, Zhejiang and 2 other locations) |
| Status | Recruiting |
| Started | December 21, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT07307560 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with STOP‑Bang ≥5 who are scheduled for a propofol‑sedated gastroscopy or colonoscopy expected to last 45 minutes or less and who can give informed consent.
✕Probably not a fit
Patients with chronic lung disease requiring long‑term oxygen, preoperative SpO2 ≤92% on room air, severe organ dysfunction, active upper respiratory infection, bleeding risk, or those who are pregnant or breastfeeding are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter randomized controlled trial compares high‑flow nasal cannula (HFNC) with standard nasal cannula during propofol‑sedated gastrointestinal endoscopy in adults identified as high risk for OSA (STOP‑Bang ≥5). Eligible patients scheduled for gastroscopy, colonoscopy, or both, with procedures expected to last 45 minutes or less, will be randomized to receive HFNC or regular nasal oxygen during the procedure. The primary outcome is the occurrence of hypoxia (oxygen desaturation) during the procedure, with safety and adverse events also recorded. Major exclusions include active upper respiratory infection, chronic pulmonary disease requiring long‑term oxygen, preoperative SpO2 ≤92% on room air, severe organ dysfunction, coagulation disorders, pregnancy, or breastfeeding.
Why it matters
Potential benefit: If successful, HFNC could reduce episodes of oxygen desaturation during sedated endoscopy, making procedures safer for high‑risk OSA patients.
How similar studies have gone: Previous small or preliminary studies suggest HFNC can reduce hypoxemia during sedation, but evidence is limited and inconsistent specifically in high‑risk OSA populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years. * STOP-Bang score ≥5. * Scheduled for sedated gastrointestinal endoscopy (gastroscopy, colonoscopy, or combined gastroscopy + colonoscopy). * The estimated duration of the procedure does not exceed 45 minutes. * Patients have signed the informed consent form. Exclusion Criteria: * Coagulation disorders or bleeding tendency (e.g., oral/nasal bleeding risk, mucosal injury, space-occupying obstructions). * Active upper respiratory tract infection (oral, nasal, or pharyngeal), or fever (core temperature \>37.5°C). * Chronic obstructive pulmonary disease or other acute/chronic pulmonary diseases requiring long-term or intermittent oxygen therapy, or preoperative SpO₂ ≤ 92% on room air. * Severe organ dysfunction, including: Cardiac insufficiency (\<4 METs), Severe renal insufficiency (requiring dialysis), Diagnosed severe hepatic insufficiency, Increased intracranial pressure, ASA physical status ≥ IV. * Confirmed pregnancy or current breastfeeding. * Known allergy to sedatives (e.g., propofol) or medical adhesives. * Multiple traumatic injuries. * Current participation in another clinical trial. * Other conditions deemed unsuitable by the investigator
Where it's running
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting -
The First Hospital Of Jiaxing
Jiaxing, Zhejiang, China Recruiting -
Quzhou People's Hospital
Quzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Diansan Su, Chief Physician
- Email: diansansu@yahoo.com
- Phone: +8618616514088
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise training after upper gastrointestinal cancer surgery
This trial tests whether high-intensity interval training or low-intensity aerobic training after curative surgery helps people recover better than usual care.
-
Using a new airway device to reduce low oxygen levels during endoscopy in obese patients
This study tests if a new airway device can help obese patients keep their oxygen levels up during gastrointestinal endoscopy compared to using a regular nasal cannula.
-
COMBO endoscopy oropharyngeal airway for safer propofol‑sedated gastrointestinal endoscopy
This trial will test whether the COMBO Endoscopy Oropharyngeal Airway reduces low-oxygen episodes in adults having propofol‑sedated gastroscopy or colonoscopy compared with a regular nasal cannula.
-
PF-08098488 in adults with advanced solid tumors
This study tests PF-08098488 in adults whose cancer has progressed or returned after prior treatment.
-
Modular Robot-Assisted Esophagectomy vs. Conventional Minimally Invasive Esophagectomy for Esophageal Cancer
This trial tests whether modular robotic-assisted esophagectomy using the Carina platform works better than conventional 3D thoracoscopic esophagectomy for people with resectable esophageal cancer.
-
F&P Mask usability in home PAP/NIV care for adults with chronic breathing conditions
This study tests how well the F&P Licorice Mask works at home for adults who already use PAP or NIV therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.